COMPARATIVE ANALYSIS OF THE RESULTS OF LABORATORY-BIOCHEMICAL ANALYSIS IN MIDDLE-AGED AND ELDERLY PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE AFTER COVID-19
Abstract
         Abstract: Several studies have shown that different clinical signs, patient age, and joint diseases may also be important in understanding the severity of the disease. Although the clinical features of COVID-19 have been extensively described, the assessment of changes in the most common biochemical markers reported in patients with COVID-19 is still poorly established. Here, we provide data on clinical and blood biochemical analyzes of 84 patients with COVID-19 and 94 patients without COVID-19. Upper airway samples were taken from patients, and real-time PCR was used to confirm SARS-CoV-2 infection. Gender, age, clinical signs, and biochemical analysis of patients were studied. Biochemical parameters were classified and analyzed according to the following clinical signs: Alanine aminotransferase (ALT), aspartate aminotransferase (ACT), creatinine, uric acid, urea, glucose, albumin, total protein, glycated hemoglobin, bilirubin, total cholesterol.